Sebastian Grosicki

country of citizenship: Poland

native language: Polish

languages spoken, written or signed: Polish

educated at: Medical University of Silesia

Sebastian Grosicki – polski hematolog, genetyk, dr hab. nauk medycznych, profesor, kierownik Oddziału Klinicznego Hematologii i Profilaktyki Chorób Nowotworowych i dziekan Wydziału Zdrowia Publicznego w Bytomiu Śląskiego Uniwersytetu Medycznego w Katowicach. Source: Wikipedia (pl)

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 83

Date

Title

Authors

2020-02-13

Refeeding syndrome in hematological cancer patients - current approach

Sebastian Grosicki
2020-02-18

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

Sarah Goldman-Mazur, Artur Jurczyszyn, Jorge Castillo, Anna Waszczuk-Gajda, Jakub Radocha, Irit Avivi, Yael C Cohen, Stuart L Goldberg, Adam J. Olszewski, CS Chim, Norbert Grzasko, Krzysztof Jamroziak, Iwona Hus, Anna Suska, Sebastian Grosicki, Ruben Niesvizky, Monika Długosz-Danecka, Jacek Czepiel, Julio Dávila, Daniel Coriu, Massimo Gentile, Alessandro Gozzetti, Lidia Usnarska-Zubkiewicz, Pawel Robak
2020-02-28

A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial

Ewa Lech-Marańda, Sebastian Grosicki, Tadeusz Robak, Janusz Kłoczko, Jerzy Z. Blonski, Javier Loscertales
2020-03-23

Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

Hareth Nahi, Philippe Moreau, Sebastian Grosicki
2020-03-31

A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial

Sebastian Grosicki, Tadeusz Robak, Janusz Kłoczko
2020-01-09

Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1

Sebastian Grosicki, Stephan Stilgenbauer
2020-01-23

Heat shock proteins as a new, promising target of multiple myeloma therapy

Sebastian Grosicki
2020-01-28

Five-year survival follow-up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine-refractory chronic lymphocytic leukaemia: a short report

Sebastian Grosicki, Grzegorz Mazur
2020-04-27

The impact of cytogenetic evolution and acquisition of del(17p) on the prognosis of multiple myeloma patients

Sebastian Grosicki, Krzysztof Jamroziak, Bartosz Pula, Katarzyna Borg
2020-05-07

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis

Anna Waszczuk-Gajda, Wiesław Jędrzejczak, Anna Czyz, Artur Jurczyszyn, Sebastian Grosicki, Marián Hajdúch, Lidia Usnarska-Zubkiewicz
2020-06-01

Demyelinating polyneuropathy and lymphoplasmacytic lymphoma coexisting in 36-year-old man: A case report

Sebastian Grosicki, Michał Holecki, Agnieszka Żak-Gołąb
2020-08-06

Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma

Nancy L Bartlett, Simon A Rule, Sebastian Grosicki
2020-09-04

Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study

Athanasios Dimopoulos, Sebastian Grosicki, Hila Magen, María Victoria Mateos, Meral Beksac, Robert Z Orlowski, Hermann Einsele, Adam Walter-Croneck
2020-10-12

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia

Marta Podgórniak, Bartosz Pula, Joanna Knap, Anna Waszczuk-Gajda, Joanna Drozd-Sokolowska, Kamil Wdowiak, Sebastian Grosicki, Izabela Kozłowska, Kamil Wiśniewski, Agnieszka Szymczyk, Marek Hus, Krzysztof Giannopoulos, Krzysztof Jamroziak, Łukasz Szukalski, Edyta Subocz
2020-11-01

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Artur Jurczyszyn, Sebastian Grosicki, Holger W Auner, Sosana Delimpasi
2019-10-18

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

Paolo Ghia, Sebastian Grosicki, Tadeusz Robak, Osnat Bairey
2019-10-29

Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)

Grzegorz Helbig, Sebastian Grosicki, Marta Sobas, Elżbieta Patkowska, Ewa Lech-Marańda, Krzysztof Warzocha, Agnieszka Wierzbowska, Marek Hus, Lukasz Bolkun, Anna Szmigielska-Kaplon, Tomasz Wróbel, Jerzy Hołowiecki, Sebastian Giebel, Tadeusz Robak, Janusz Kłoczko, Olga Grzybowska-Izydorczyk, Ewa Wawrzyniak, Wanda Knopinska-Posluszny
2019-11-08

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

Catherine Thieblemont, René-Olivier Casasnovas, Dominique Bron, Sebastian Grosicki, Reda Bouabdallah, Franck Morschhauser, Hervé Tilly, Aurore Perrot, Koen Van Eygen, Amos M Cohen, Nicolas Mounier, Christophe Fruchart, Gian Matteo Pica, Olivier Fitoussi, Sylvia Snauwaert, Judith Trotman, Philippe Gaulard
2019-12-04

Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study

Sebastian Grosicki
2019-12-10

Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial

Paulo Lucio, Jesús San Miguel, Sebastian Grosicki, Tomoaki Fujisaki, Genadi Iosava, Jon Ukropec, Rachel Kobos, Michele Cavo, Andrzej Jakubowiak, Mamta Garg, Kenshi Suzuki
2019-09-30

Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience

Grzegorz Helbig, Marzena Wątek, Miguel A Sanz, Krzysztof Lewandowski, Agnieszka Wierzbowska, Monika Podhorecka, Anna Czyz, Grzegorz Charlinski, Sebastian Giebel, Sebastian Grosicki, Aleksandra Gołos, Jadwiga Hołojda, Aleksandra Hołowiecka-Goral, Maciej Majcherek
2018-01-03

Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study

Sebastian Grosicki
2018-02-01

The importance of antiangiogenic effect in multiple myeloma treatment

Karolina Krupa-Kotara, Sebastian Grosicki
2018-10-12

Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

Sebastian Grosicki, Nancy L Bartlett, Simon A Rule
2018-11-01

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma

Sebastian Grosicki, Jesús San Miguel, Philippe Moreau, Paul G. Richardson, Marc S Raab, Athanasios Dimopoulos, Dominik Dytfeld, Kenshi Suzuki, Naoki Takezako, Suresh G Shelat
2018-06-07

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2

Nancy L Bartlett, Sebastian Grosicki, Paolo Ghia, Tadeusz Robak, Osnat Bairey
2018-10-09

Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies

Tadeusz Robak, Sebastian Grosicki, Paolo Ghia
2018-07-30

Recommendations for the diagnosis and treatment of patients with polycythaemia vera

Antónia Hatalova, Serhii Klymenko, Sebastian Grosicki, Heinz Gisslinger, Andrzej Hellmann, Maria Podolak-Dawidziak
2018-01-01

Evaluation on inflammatory states of peripheral veins connected with cannulation /

Sebastian Grosicki
2018-01-01

Improving the effectiveness of obesity treatment by combining a diet and motivational techniques

Sebastian Grosicki, Beata Całyniuk
2018-11-20

Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma

Shaji K Kumar, Norbert Grzasko, Sebastian Grosicki, Neeraj Gupta, Athanasios Dimopoulos, Wiesław Jędrzejczak, Sosana Delimpasi
2018-11-22

All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Sebastian Grosicki, Hareth Nahi, Norbert Grzasko, Wiesław Jędrzejczak, Shaji K Kumar

Human - wd:Q83782446

Welcome to Inventaire

the library of your friends and communities

learn more